Download our new White Paper now: Environmental Beneﬁts of NorthStar Medical Radioisotopes’ Non–Uranium-Based Production Method for Molybdenum-99/Technetium-99m
Our innovative products and technologies define a new era in current and future diagnostic and therapeutic radiopharmaceuticals.
We lead the way in producing stable, reliable, domestically-sourced, environmentally-friendly radioisotope supply to meet critical patient healthcare needs and advance clinical research.
Our people drive our solutions in advancing radioisotope technology to shape a better world.
We are a recognized, emerging global leader with a proven track record and strong vision for the future of radiopharmaceuticals. Our innovation-driven technology is transforming the landscape for medical radioisotope production and distribution around the world.
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2023 Guggenheim Radiopharmaceuticals DayRead More >
NorthStar Medical Radioisotopes Expands Management Team with Appointment of Jean-Noel David, MBA, MS, as Vice President, OperationsRead More >
NorthStar Medical Radioisotopes Announces Promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic TechnologiesRead More >
NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming MilestonesRead More >